TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target

PURPOSE: Vulvar squamous cell carcinoma (VSCC) is a rare malignancy of the female genital tract with increasing incidence rates. Etiologically, HPV-dependent and HPV-independent VSCC are distinguished. Surgical treatment and/or radiotherapy represent the therapeutic mainstay for localized disease. F...

Descripción completa

Detalles Bibliográficos
Autores principales: Condic, Mateja, Egger, Eva K., Klümper, Niklas, Kristiansen, Glen, Mustea, Alexander, Thiesler, Thore, Ralser, Damian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374825/
https://www.ncbi.nlm.nih.gov/pubmed/37067548
http://dx.doi.org/10.1007/s00432-023-04761-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374825/
https://www.ncbi.nlm.nih.gov/pubmed/37067548
http://dx.doi.org/10.1007/s00432-023-04761-8

Ejemplares similares